| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MED | Common Stock | Award | $0 | +34.1K | +241.37% | $0.00 | 48.2K | Feb 24, 2023 | Direct | F1 |
| transaction | MED | Common Stock | Tax liability | -$1.72M | -15.6K | -32.46% | $109.99 | 32.6K | Feb 24, 2023 | Direct | F1 |
| transaction | MED | Common Stock | Tax liability | -$142K | -1.36K | -4.17% | $104.46 | 31.2K | Mar 16, 2023 | Direct | |
| transaction | MED | Common Stock | Tax liability | -$89.6K | -872 | -2.8% | $102.75 | 30.3K | Mar 17, 2023 | Direct | |
| transaction | MED | Common Stock | Award | $0 | +16.8K | +55.43% | $0.00 | 47.1K | Mar 17, 2023 | Direct | F2 |
| holding | MED | Common Stock | 109K | Feb 24, 2023 | The Dan and Allyson Family Irrevocable Trust | F3 |
| Id | Content |
|---|---|
| F1 | 17,038 Performance Stock Units were granted on February 19, 2020, and vested on December 31, 2022 and converted into common stock on a two-for-one basis due to the achievement of certain performance factors. The Compensation Committee of the Medifast Board of Directors approved the performance factors on February 24, 2023 and the shares were released on March 7, 2023. |
| F2 | Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
| F3 | These shares are directly owned by The Dan and Allyson Family Irrevocable Trust, for which the reporting person is the Settlor of the Trust and Investment Trustee. |